Adding bile acids as farnesoid X receptor agonists to the culture medium supported the growth and development of unique stem cell-derived hepatic organoids, report researchers from Japan. These three-dimensional liver organoids ...
Jul 7, 2025
0
0
Alcohol advertising is everywhere—on TV, bus shelters, and social media. As a parent, keeping track of what your child sees can seem impossible. So, should we be concerned about children being exposed to alcohol ads?
Jun 16, 2025
0
0
During the first meeting of the Global Think-tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on 5–6 June, more than 100 international ...
Jun 6, 2025
0
0
New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and ...
May 20, 2025
0
0
Distinct trends were seen in etiology-based mortality with chronic liver disease (CLD) before, during, and after the COVID-19 pandemic, according to a research letter published online April 29 in the Annals of Internal Medicine.
May 8, 2025
0
0
An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent condition that affects around 2 million people in the UK.
May 8, 2025
0
1
Adults younger than 50 years of age had more than double the risk of having a stroke from migraine or other nontraditional stroke risk factors rather than traditional risks such as high blood pressure, according to research ...
Apr 17, 2025
0
0
Johns Hopkins University-led research has found that obesity, particularly severe obesity, is strongly associated with the incidence of 16 common health outcomes. Associations remained consistent across sex and racial groups. ...
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.
Mar 25, 2025
0
0
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC) and hepatic decompensation among patients with chronic liver disease (CLD). Statins, particularly ...
